These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7359643)

  • 1. Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods.
    Romas NA; Veenema RJ; Hsu KC; Tomashefsky P; Lattimer JK; Tannenbaum M
    J Urol; 1980 Mar; 123(3):392-5. PubMed ID: 7359643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods.
    Romas NA; Veenema RJ; Hsu KC; Tomashefsky P; Lattimer JK; Tannenbaum M
    Trans Am Assoc Genitourin Surg; 1979; 71():26-30. PubMed ID: 545810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow acid phosphatase in staging of prostatic cancer: how reliable is it?
    Pontes JE; Choe BK; Rose NR; Pierce JM
    J Urol; 1978 Jun; 119(6):772-6. PubMed ID: 660763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic cancer. Immunochemical detection of prostatic acid phosphatase in serum and bone marrow.
    Catane R; Madajewicz S; Wajsman ZL; Chu TM; Mittelman A; Murphy GP
    N Y State J Med; 1978 Jun; 78(7):1060-1. PubMed ID: 275612
    [No Abstract]   [Full Text] [Related]  

  • 5. Reliability of bone marrow acid phosphatase as a parameter of metastatic prostatic cancer.
    Pontes JE; Choe B; Rose N; Pierce JM
    J Urol; 1979 Aug; 122(2):178-9. PubMed ID: 459010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow and acid phosphatase by counterimmune electrophoresis: pre-treatment and post-treatment correlations.
    Schellhammer PF; Warden SS; Wright GL; Sieg SM
    J Urol; 1982 Jan; 127(1):66-8. PubMed ID: 7057508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
    Vihko P; Kontturi M; Lukkarinen O; Vihko R
    J Urol; 1982 Oct; 128(4):739-41. PubMed ID: 6183458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined serum and bone marrow radioimmunoassays for prostatic acid phosphatase.
    Cooper JF; Foti A; Herschman H
    J Urol; 1979 Oct; 122(4):498-502. PubMed ID: 480493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of prostatic acid phosphatase in serum and bone marrow: radioimmunoassay and enzymic measurement compared.
    Huber PR; Scholer A; Linder E; Hagmaier V; Vogt H; Christen P; Eppenberger U; Rutishauser G
    Clin Chem; 1982 Oct; 28(10):2044-50. PubMed ID: 7127733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid phosphatase.
    Henneberry MO; Engel G; Grayhack JT
    Urol Clin North Am; 1979 Oct; 6(3):629-41. PubMed ID: 388794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An objective look at acid phosphatase determinations: a comparison of biochemical and immunological methods.
    Bruce AW; Mahan DE; Morales A; Clark AF; Belville WE
    Br J Urol; 1979 Jun; 51(3):213-7. PubMed ID: 380731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of bone marrow acid phosphatase in patients with prostatic carcinoma.
    Fosså SD; Sokolowski J; Theodorsen L
    Br J Urol; 1978 May; 50(3):185-9. PubMed ID: 753458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
    Fossà SD; Skinningsrud A; Kaalhus O; Engeset A
    Br J Urol; 1983 Jun; 55(3):306-11. PubMed ID: 6850249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of gallbladder simulating metastatic prostatic cancer.
    Goldstein HR; Wechsler M; Saruk M
    Urology; 1979 Dec; 14(6):597-9. PubMed ID: 516214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow acid phosphatase by radioimmunoassay: 3 years of experience.
    Belville WD; Mahan DE; Sepulveda RA; Bruce AW; Miller CF
    J Urol; 1981 Jun; 125(6):809-11. PubMed ID: 7241679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum and bone marrow acid phosphatase.
    Pontes JE
    Prostate; 1980; 1(4):465-70. PubMed ID: 7024959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of bone marrow acid phosphatase in prostatic carcinoma.
    Alsabti EA; Safo M
    Urol Int; 1979; 34(5):350-5. PubMed ID: 494437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of bone marrow acid phosphatase and bone scanning in staging of prostatic cancer.
    Gursel EO; Rezvan M; Sy FA; Veenema RJ
    J Urol; 1974 Jan; 111(1):53-7. PubMed ID: 4813553
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunochemical measurement of serum prostatic acid phosphatase (PAP). Clinical evaluation of radioimmunoassay and counter immunoelectrophoresis.
    Gupta MK; Rajaraman S; Gupta SK; Hewitt CB; Deodhar SD
    Am J Clin Pathol; 1981 Oct; 76(4):430-6. PubMed ID: 6170220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and immunologic techniques for acid phosphatase measurement in the diagnosis of prostate cancer.
    Chu TM
    Natl Cancer Inst Monogr; 1978 Dec; (49):239. PubMed ID: 748777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.